D. Tran‐Thanh

发表

CCN3 impairs osteoblast and stimulates osteoclast differentiation to favor breast cancer metastasis to bone.

Véronique Ouellet, Svetlana V Komarova, Mark Clemons, 2011, The American journal of pathology.

Molecular classification of infiltrating breast cancer: toward personalized therapy.

M. Labelle, I. Trop, M. El Khoury, 2014, Radiographics : a review publication of the Radiological Society of North America, Inc.

Cyclooxygenase-2 Inhibition for the Prophylaxis and Treatment of Preinvasive Breast Cancer in a Her-2/Neu Mouse Model

S. Done, Stephen D. Buttars, Christine Wilson, 2010, Cancer Prevention Research.

Hematoxylin and Eosin Counterstaining Protocol for Immunohistochemistry Interpretation and Diagnosis

B. Gilks, R. Albadine, Andrée-Anne Grosset, 2017, Applied immunohistochemistry & molecular morphology : AIMM.

A Multicenter Phase II Clinical Trial of Lapatinib (GW572016) in Hormonally Untreated Advanced Prostate Cancer

Joseph L. Chin, John Trachtenberg, Lisa Wang, 2010, American journal of clinical oncology.

Expression of Abl interactor 1 and its prognostic significance in breast cancer: a tissue-array-based investigation

Susan J. Done, L. Jacks, D. McCready, 2011, Breast Cancer Research and Treatment.

Male pseudohermaphroditism and gonadal mosaicism in a 47,XY,+22 fetus

E. Lemyre, D. Bouron‐Dal Soglio, J. Fournet, 2006, American journal of medical genetics. Part A.

Herpes simplex virus type II is not a cofactor to human papillomavirus in cancer of the uterine cervix.

C. Wheeler, D. Provencher, E. Franco, 2003, American journal of obstetrics and gynecology.

Proteomic Analyses Reveal High Expression of Decorin and Endoplasmin (HSP90B1) Are Associated with Breast Cancer Metastasis and Decreased Survival

Moyez Dharsee, Katherine A. Vallis, Susan J. Done, 2012, PloS one.

Tepotinib efficacy in an NSCLC patient with brain metastasis harboring an HLA-DRB1-MET gene fusion.

A. Iafrate, B. Routy, C. Leduc, 2020, The oncologist.

Amplification of the prolactin receptor gene in mammary lobular neoplasia

M. Pintilie, N. Arneson, S. Done, 2011, Breast Cancer Research and Treatment.

CANTRK: A Canadian Ring Study to Optimize Detection of NTRK Gene Fusions by Next Generation RNA Sequencing.

H. Feilotter, S. Yip, M. Tsao, 2022, The Journal of molecular diagnostics : JMD.

Consensus Recommendations to Optimize the Detection and Reporting of NTRK Gene Fusions by RNA-Based Next-Generation Sequencing

H. Feilotter, S. Yip, D. Grafodatskaya, 2023, Current oncology.

A phase II study of erlotinib in gemcitabine refractory advanced pancreatic cancer.

M. Tsao, D. Hedley, M. Moore, 2014, European journal of cancer.

Improvement of EGFR Testing over the Last Decade and Impact of Delaying TKI Initiation

B. Routy, D. Tran-Thanh, N. Blais, 2021, Current oncology.

Canadian Anaplastic Lymphoma Kinase Study: A Model for Multicenter Standardization and Optimization of ALK Testing in Lung Cancer

B. Blencowe, A. Iafrate, A. Karsan, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Chronic granulomatous mastitis: Imaging, pathology and management.

M. Labelle, I. Trop, M. El Khoury, 2013, European journal of radiology.

Amplification of a calcium channel subunit CACNG4 increases breast cancer metastasis

T. Mak, A. Pasculescu, A. Datti, 2020, EBioMedicine.

Sequential targeting of PARP with carboplatin inhibits primary tumour growth and distant metastasis in triple-negative breast cancer

T. Haque, S. Hassan, M. Beniey, 2023, British Journal of Cancer.

A Pan-Canadian Validation Study for the Detection of EGFR T790M Mutation Using Circulating Tumor DNA From Peripheral Blood

H. Feilotter, D. Demetrick, D. Grafodatskaya, 2021, JTO clinical and research reports.

Systemic Therapy in Local Recurrence of Breast Cancer, Report of a case and Decision Making in MDT Meeting

L. Yelle, R. Younan, E. Patocskai, 2019, Archives of Breast Cancer.

Survival Impact of Aggressive Treatment and PD-L1 Expression in Oligometastatic NSCLC

L. Gaboury, R. Albadine, B. Routy, 2021, Current oncology.

Canadian ROS proto-oncogene 1 study (CROS) for multi-institutional implementation of ROS1 testing in non-small cell lung cancer.

A. Karsan, Y. Yatabe, M. Tsao, 2021, Lung cancer.

Mitochondrial D310 mutations in the early development of breast cancer

S. Done, J. Vecchiarelli, K. May, 2012, British Journal of Cancer.

Canadian ALK (CALK): A pan-Canadian multicenter study to optimize and standardize ALK immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) for ALK gene rearrangements.

A. Karsan, Y. Yatabe, M. Tsao, 2013 .

Mapping genomic and transcriptomic alterations spatially in epithelial cells adjacent to human breast carcinoma

Natalie S. Fox, P. Boutros, D. McCready, 2017, Nature Communications.

Detection of human herpes virus type 6 DNA in precancerous lesions of the uterine cervix

D. Provencher, E. Franco, A. Koushik, 2002, Journal of medical virology.

The prognostic impact of KRAS, TP53, STK11 and KEAP1 mutations and their influence on the NLR in NSCLC patients treated with immunotherapy.

N. Blais, M. Tehfé, M. Florescu, 2023, Cancer treatment and research communications.

The role of stromal factors in breast tumorigenicity.

S. Done, D. Tran-Thanh, D. Tran‐Thanh, 2010, The American journal of pathology.